Eiger Expects To Join Gilead In Future Multi-Billion Dollar Hepatitis D Market

Also Set For COVID-19 EUA

 
• By Andrew McConaghie

The little-known company could be set for a transformational year, with a Phase III readout in hepatitis D and a filing for a promising COVID-19 candidate.

Liver disease
An estimated 12 million people worldwide have the hepatitis D infection. • Source: Shutterstock

More from Business

More from Scrip